---All---
  • ---All---
  • Accession
  • Catalog #

MLH1 Antibody (Center) Blocking PeptidesSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP11686c 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

MLH1 Antibody (Center) Blocking Peptides - Product info

Primary AccessionP40692
Clone Names80821077
Calculated MW84601 Da

MLH1 Antibody (Center) Blocking Peptides - Additional info

Gene ID 4292
Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

MLH1 Antibody (Center) Blocking Peptides - Protein Information

Name MLH1
Synonyms COCA2
Function
Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS- heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma which plays a role in meiosis
Cellular Location
Nucleus.
Tissue Location
Colon, lymphocytes, breast, lung, spleen, testis, prostate, thyroid, gall bladder and heart

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes a protein that may function in tumorsuppression. This protein binds to and colocalizes with the breastcancer 2 early onset protein (BRCA2) in nuclear foci and likelypermits the stable intranuclear localization and accumulation ofBRCA2.

REFERENCES

Dray, E., et al. Nat. Struct. Mol. Biol. 17(10):1255-1259(2010)Buisson, R., et al. Nat. Struct. Mol. Biol. 17(10):1247-1254(2010)Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Adank, M.A., et al. Pediatr Blood Cancer 55(4):742-744(2010)Guenard, F., et al. Genet Test Mol Biomarkers 14(4):515-526(2010)